{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:01:19Z","timestamp":1780023679916,"version":"3.53.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"DOI":"10.1007\/s12308-026-00707-4","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T13:40:32Z","timestamp":1779975632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinicopathological characteristics of a rare group of chronic active Epstein-Barr virus disease involving the gastrointestinal tract"],"prefix":"10.1007","volume":"19","author":[{"given":"Xiaodan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"7335","key":"707_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein MA, Achong BG, Barr YM (1964) Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma. Lancet 1(7335):702\u2013703","journal-title":"Lancet"},{"issue":"1","key":"707_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1128\/JVI.72.1.158-163.1998","volume":"72","author":"X Wang","year":"1998","unstructured":"Wang X, Hutt-Fletcher LM (1998) Epstein-Barr virus lacking glycoprotein gp42 can bind to B cells but is not able to infect. J Virol 72(1):158\u2013163","journal-title":"J Virol"},{"issue":"2","key":"707_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0092-8674(87)90216-9","volume":"50","author":"J Tanner","year":"1987","unstructured":"Tanner J, Weis J, Fearon D et al (1987) Epstein-Barr virus gp350\/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell 50(2):203\u2013213","journal-title":"Cell"},{"issue":"1","key":"707_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1182\/blood.2023021074","volume":"143","author":"J Wang","year":"2024","unstructured":"Wang J, Su M, Wei N et al (2024) Chronic active Epstein-Barr virus disease originates from infected hematopoietic stem cells. Blood 143(1):32\u201341","journal-title":"Blood"},{"issue":"12","key":"707_CR5","doi-asserted-by":"publisher","first-page":"5993","DOI":"10.4049\/jimmunol.170.12.5993","volume":"170","author":"J Tabiasco","year":"2003","unstructured":"Tabiasco J, Vercellone A, Meggetto F et al (2003) Acquisition of viral receptor by NK cells through immunological synapse. J Immunol 170(12):5993\u20135998","journal-title":"J Immunol"},{"issue":"7","key":"707_CR6","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI (2000) Epstein-Barr virus infection. N Engl J Med 343(7):481\u2013492","journal-title":"N Engl J Med"},{"key":"707_CR7","doi-asserted-by":"crossref","unstructured":"Alaggio R, Amador C, Anagnostopoulos I et al (2022) The 5th edition of the World Health Organization classifcation of haematolymphoid tumours: lymphoid neo-plasms. Leukemia 36(7):1720\u20131748","DOI":"10.1038\/s41375-022-01620-2"},{"issue":"9","key":"707_CR8","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/annonc\/mdp064","volume":"20","author":"JI Cohen","year":"2009","unstructured":"Cohen JI, Kimura H, Nakamura S et al (2009) Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8\u20139 September 2008. Ann Oncol 20(9):1472\u20131482","journal-title":"Ann Oncol"},{"key":"707_CR9","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood.V98.10.3173","volume":"98","author":"K Kawa","year":"2001","unstructured":"Kawa K, Okamura T, Yagi K et al (2001) Mosquito allergy and Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease. Blood 98:3173\u20133174","journal-title":"Blood"},{"key":"707_CR10","unstructured":"Quintanilla-Martinez L, Ko YH, Kimura H (2017) EBV\u2013positive T-cell and NK-cell lymphoproliferative diseases of childhood. In: Swerdlow SH, Campo E, Harris NL, Jaffffe ES, Pileri SA, Stein H (eds) WHO Classifification of Tumours of haematopoietic and lymphoid tissues, revised 4th ed. WHO IARC Press, Lyon, pp 355\u2013362"},{"issue":"5","key":"707_CR11","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s12185-011-0831-x","volume":"93","author":"A Arai","year":"2011","unstructured":"Arai A, Imadome KI, Watanabe Y et al (2011) Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis. Int J Hematol 93(5):602\u2013609","journal-title":"Int J Hematol"},{"key":"707_CR12","doi-asserted-by":"crossref","unstructured":"Yasushi Isobe\u00a01,\u00a0Nanae Aritaka,\u00a0Yasuhiro Setoguchi et al (2012) T\/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T\/NK-cell lymphoma. J Clin Pathol 65(3):278\u2013282","DOI":"10.1136\/jclinpath-2011-200523"},{"issue":"6","key":"707_CR13","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3324\/haematol.2017.174177","volume":"103","author":"K Kawamoto","year":"2018","unstructured":"Kawamoto K, Miyoshi H, Suzuki T et al (2018) A distinct subtype of Epstein-Barr virus-positive T\/NK-cell lymphoproliferative disorder: Adult patients with chronic active Epstein-Barr virus infection-like features. Haematologica 103(6):1018\u20131028","journal-title":"Haematologica"},{"issue":"17","key":"707_CR14","first-page":"1322","volume":"105","author":"Lymphocyte Group of Hematology Branch of the Chinese Medical Association","year":"2025","unstructured":"Lymphocyte Group of Hematology Branch of the Chinese Medical Association, Hematology Group of Pediatrics Branch of the Chinese Medical Association, Infectious Disease Branch of the Chinese Medical Association (2025) Expert consensus on diagnosis and treatment of chronic active Epstein-Barr virus disease (2025 edition). Zhonghua Bing Li Xue Za Zhi 105(17):1322\u20131330","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"10","key":"707_CR15","first-page":"725","volume":"45","author":"W Shi","year":"2016","unstructured":"Shi W, Jiang ZN (2016) Chronic active Epstein-Barr virus enteritis: Report of a case. Zhonghua Bing Li Xue Za Zhi 45(10):725\u2013726","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"7","key":"707_CR16","first-page":"487","volume":"57","author":"XY Dong","year":"2018","unstructured":"Dong XY, Li J, Li Y et al (2018) The clinical characteristics of immunocompetent adults with chronic active Epstein-Barr virus associated enteritis. Zhonghua Nei Ke Za Zhi 57(7):487\u2013493","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"6","key":"707_CR17","first-page":"371","volume":"38","author":"XZ Yang","year":"2020","unstructured":"Yang XZ, Zheng JM, Li RK et al (2020) Three cases of chronic active EBV infection associated enteritis. Chin J Infect Dis 38(6):371\u2013373","journal-title":"Chin J Infect Dis"},{"issue":"5","key":"707_CR18","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1097\/MIB.0000000000000726","volume":"22","author":"KA Chachu","year":"2016","unstructured":"Chachu KA, Osterman MT (2016) How to diagnose and treat IBD mimics in the refractory IBD patient who does not have IBD. Inflamm Bowel Dis 22(5):1262\u20131274","journal-title":"Inflamm Bowel Dis"},{"issue":"5","key":"707_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s12185-023-03660-5","volume":"118","author":"J-I Kawada","year":"2023","unstructured":"Kawada J-I, Ito Y, Ohshima K et al (2023) Updated guidelines for chronic active Epstein\u2013Barr virus disease. Int J Hematol 118(5):568\u2013576","journal-title":"Int J Hematol"},{"issue":"1","key":"707_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/ajcp\/aqv010","volume":"145","author":"Y Huang","year":"2016","unstructured":"Huang Y, Xie J, Ding Y et al (2016) Extranodal natural killer\/T-cell lymphoma in children and adolescents: a report of 17 cases in China. Am J Clin Pathol 145(1):46\u201354","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"707_CR21","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJ Van Dongen","year":"2023","unstructured":"Van Dongen JJ, Langerak AW, Bruggemann M et al (2023) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17(12):2257\u20132317","journal-title":"Leukemia"},{"issue":"1","key":"707_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/rmv.441","volume":"15","author":"T Tsurumi","year":"2005","unstructured":"Tsurumi T, Fujita M, Kudoh A (2005) Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol 15(1):3\u201315","journal-title":"Rev Med Virol"},{"issue":"3","key":"707_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/01.inf.0000154335.48682.af","volume":"24","author":"DE Roth","year":"2005","unstructured":"Roth DE, Jones A, Smith L et al (2005) Severe chronic active Epstein-Barr virus infection mimicking steroid-dependent inflammatory bowel disease. Pediatr Infect Dis J 24(3):261\u2013264","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"707_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8919","volume":"12","author":"Y Meng","year":"2024","unstructured":"Meng Y, Li R, Ding JieWen et al (2024) Clinical characteristics and literature review of chronic active Epstein-Barr virus-associated enteritis. Clin Case Rep 12(6):e8919","journal-title":"Clin Case Rep"},{"key":"707_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01867","volume":"8","author":"H Kimura","year":"2017","unstructured":"Kimura H, Cohen JI (2017) Chronic active Epstein-Barr virus disease. Front Immunol 8:1867","journal-title":"Front Immunol"},{"issue":"3","key":"707_CR26","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41379-018-0144-1","volume":"32","author":"RB Liu","year":"2019","unstructured":"Liu RB, Wang MY, Zhang LZ et al (2019) The clinicopathologic features of chronic active Epstein-Barr virus infective enteritis. Mod Pathol 32(3):387\u2013395","journal-title":"Mod Pathol"},{"issue":"1","key":"707_CR27","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1002\/ajh.20398","volume":"80","author":"M Okano","year":"2005","unstructured":"Okano M, Kawa K, Kimura H et al (2005) Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 80(1):64\u201369","journal-title":"Am J Hematol"},{"issue":"4","key":"707_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1440-1827.2008.02213.x","volume":"58","author":"K Ohshima","year":"2008","unstructured":"Ohshima K, Kimura H, Yoshino T et al (2008) Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 58(4):209\u2013217","journal-title":"Pathol Int"},{"issue":"3","key":"707_CR29","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","volume":"119","author":"H Kimura","year":"2012","unstructured":"Kimura H, Ito Y, Kawabe S et al (2012) EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood 119(3):673\u2013686","journal-title":"Blood"},{"issue":"3","key":"707_CR30","first-page":"1281","volume":"11","author":"Y-L Zhang","year":"2018","unstructured":"Zhang Y-L, Xie J-L, Wei P et al (2018) EBV-positive T\/NK lymphoproliferative diseases: analysis of prognostic factors for patients in China. Int J Clin Exp Pathol 11(3):1281\u20131288","journal-title":"Int J Clin Exp Pathol"},{"issue":"4","key":"707_CR31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1086\/427239","volume":"191","author":"H Kimura","year":"2005","unstructured":"Kimura H, Hoshino Y, Hara S et al (2005) Diferences between T cell-type and natural killer celltype chronic active Epstein-Barr virus infection. J Infect Dis 191(4):531\u2013539","journal-title":"J Infect Dis"},{"key":"707_CR32","unstructured":"Xiao-Dan Zheng\u00a01,\u00a0Xiao-Ge Zhou,\u00a0Yan Jin, et al (2011) Clinicopathologic features of systemic EBV-positive T\/NK-cell lymphoproliferative disease in adults. Zhonghua Bing Li Xue Za Zhi 40(4):227\u2013234."},{"issue":"6","key":"707_CR33","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1097\/01.tp.0000202724.07714.a2","volume":"81","author":"A Humar","year":"2006","unstructured":"Humar A, Hebert D, Davies HD et al (2006) A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder. Transplantation 81(6):856\u2013861","journal-title":"Transplantation"},{"issue":"4","key":"707_CR34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/jclinpath-2013-201905","volume":"67","author":"ST Chang","year":"2014","unstructured":"Chang ST, Lu YH, Lu CL et al (2014) Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time. J Clin Pathol 67(4):326\u2013332","journal-title":"J Clin Pathol"},{"issue":"5","key":"707_CR35","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/ecco-jcc\/jjv040","volume":"9","author":"LH Nissen","year":"2015","unstructured":"Nissen LH, Nagtegaal ID, de Jong DJ et al (2015) Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders. J Crohns Colitis 9(5):398\u2013403","journal-title":"J Crohns Colitis"},{"issue":"3","key":"707_CR36","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/blood-2007-01-067769","volume":"110","author":"S Park","year":"2007","unstructured":"Park S, Lee J, Ko YH et al (2007) The impact of Epstein-Barr virus status on clinical outcome in diffuse large Bcell lymphoma. Blood 110(3):972\u2013978","journal-title":"Blood"},{"issue":"4","key":"707_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1086\/367988","volume":"187","author":"H Kimura","year":"2003","unstructured":"Kimura H, Morishima T, Kanegane H et al (2003) Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 187(4):527\u2013533","journal-title":"J Infect Dis"},{"issue":"1","key":"707_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1053\/j.semdp.2019.12.004","volume":"37","author":"IA Montes-Mojarro","year":"2020","unstructured":"Montes-Mojarro IA, Kim WY, Fend F et al (2020) EpsteinBarr virus positive T and NK-cell lymphoproliferations: morphological features and differential diagnosis. Semin Diagn Pathol 37(1):32\u201346","journal-title":"Semin Diagn Pathol"},{"issue":"3","key":"707_CR39","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S1040-8428(02)00118-X","volume":"44","author":"M Okano","year":"2002","unstructured":"Okano M (2002) Overview and problematic standpoints of severe chronic active Epstein-Barr virus infection syndrome. Crit Rev Oncol Hematol 44(3):273\u2013282","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"707_CR40","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12876-020-01589-1","volume":"21","author":"Y Aihara","year":"2021","unstructured":"Aihara Y, Moriya K, Shimozato N et al (2021) Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report. BMC Gastroenterol 21(1):6","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"707_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/gut.36.2.311","volume":"36","author":"EF Posthuma","year":"1995","unstructured":"Posthuma EF, Westendorp RG, van der Sluys Veer A et al (1995) Fatal infectious mononucleosis: a severe complication in the treatment of Crohn\u2019s disease with azathioprine. Gut 36(2):311\u2013313","journal-title":"Gut"},{"issue":"5","key":"707_CR42","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1053\/j.gastro.2007.09.001","volume":"133","author":"S Nikolaus","year":"2007","unstructured":"Nikolaus S, Schreiber S (2007) Diagnostics of inflammatory bowel disease. Gastroenterology 133(5):1670\u20131689","journal-title":"Gastroenterology"},{"issue":"11","key":"707_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112679","volume":"13","author":"KE Kim","year":"2021","unstructured":"Kim KE, Jang M, Yang IW et al (2021) Primary gastrointestinal T\/NK cell lymphoma. Cancers (Basel) 13(11):2679","journal-title":"Cancers (Basel)"},{"key":"707_CR44","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.16_suppl.7016","volume":"43","author":"X Wang","year":"2025","unstructured":"Wang X, Luo H, An N et al (2025) Worldwide experience of chronic active EBV infection: retrospective cohort study. J Clin Oncol 43:7016. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.7016","journal-title":"J Clin Oncol"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00707-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-026-00707-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-026-00707-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T02:01:49Z","timestamp":1780020109000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-026-00707-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["707"],"URL":"https:\/\/doi.org\/10.1007\/s12308-026-00707-4","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"8 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u00a0The author(s) received no financial support for the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were conducted in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and the Helsinki Declaration of 1964 and its later versions. Ethical approval was obtained from the Ethical Review Board of the Beijing Friendship Hospital, Capital Medical University (No. 2026-P2-060-01).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all the participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Consent for publication was obtained from all the individuals included in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"25"}}